NAVIZIXBusiness Made Navigable.Beta
Create free account
All playbooksStartup & tech

Biotech lab playbook.

A London / Cambridge / Oxford biotech lab running wet-lab R&D in therapeutics, diagnostics, synthetic biology, agri-bio or industrial bio. The win is generating reproducible pre-clinical / discovery data that unlocks the next funding round (Innovate UK / ARIA / Wellcome Leap / dilutive VC) or a pharma BD deal.

Claim a founding seator book a demo →
Overview

A London / Cambridge / Oxford biotech is fundamentally a programme business — every month is bought by a milestone that unlocks the next tranche. The biggest lever is non-dilutive funding: Innovate UK + ARIA + Wellcome Leap + SBRI + EIC can fund 50–80% of pre-clinical cost. The second lever is R&D tax credits (27% effective relief, SME scheme). The third lever is wet-lab choice — converting raw space is £400–£900 / ft² + 9–14 months; using BioLabs / Stevenage / Babraham / Oxford Sciences Park co-lab cuts this to 30 days at £3,400–£8,400 / FTE / month. This playbook covers operationalising a London biotech from pre-seed wet-lab launch through first IND-enabling data and £1m–£10m raised.

18–32%
Innovate UK biomedical grant conversion (top quartile)
27% effective relief on qualifying R&D
UK R&D tax credit (SME, 2026)
£3,400–£8,400 incl. consumables
Wet-lab cost per FTE / month (CL2 in London)
№ 01 / What you'll need

Equipment list with real 2026 UK prices.

Sized for a 2–4 chair shop. Buy mid-range on chairs and clippers; cheap kit fails inside 12 months and walks away with your barbers.

01

Wet-lab benches + safety (CL2)

Bench + fume hood + CL2 cabinet per FTE
£8,400–£24,000 setup or co-lab inclusive
−80°C + −20°C freezers + cryo storage
£8,400–£42,000 + LN2 contract
Autoclave + glasswash + waste-disposal contract
£3,400–£14,000 + £400–£1,400 / month
02

Instruments + assays

Plate reader + PCR / qPCR + centrifuge bench
£24,000–£140,000 one-off
Flow cytometer / NGS / mass-spec (or CRO access)
£82,000–£480,000 capex or per-sample
Cryo-EM / microscopy (shared facility)
£200–£1,800 / session at Diamond / Crick / Francis Crick Institute
Compute (AWS / GCP for NGS / cryo-EM / structure)
£800–£14,000 / month
03

Compliance + ops

HRA / MHRA / HSE / HTA registration + biosafety officer
£14,000–£60,000 / yr
ISO 15189 (diagnostics) / ISO 13485 (medical device) / GxP (therapeutics)
£24,000–£140,000 / yr
IP + patent attorney + freedom-to-operate searches
£14,000–£82,000 / yr
PI + product-liability + employer's liability + cyber
£3,400–£28,000 / yr
R&D-tax-credit accountant + grant-claim specialist
8–12% success fee + base £8k–£28k / yr
№ 02 / Where to set up

Location is half the business.

Wet-lab co-space + KOL density
Within 30 min of BioLabs King's Cross / Stevenage Bioscience / Babraham / Oxford BioEscalator

Co-lab cuts setup from 9 months to 30 days; KOL + pharma BD proximity halves sales cycle.

Investor + grant cluster
Within 60 min of London / Cambridge / Oxford

Biotech VCs (SV Health / Sofinnova / Forbion / Syncona) + ARIA + Wellcome + Innovate UK all UK-anchored.

Talent + university recruitment
Within 45 min of Imperial / UCL / KCL / Crick / Cambridge / Oxford

Post-doc + technician recruitment is local; relocation kills runway.

Area tier
Rent / month
Notes
BioLabs King's Cross (N1C)
£3,400–£8,400 / FTE incl. bench + shared equipment
Best mix of London talent + KOL access; expensive but fast.
Stevenage Bioscience Catalyst (SG1)
£1,800–£4,800 / FTE
GSK-adjacent; pharma BD warm; cheaper than London.
Babraham / Cambridge / Oxford BioEscalator
£1,400–£4,800 / FTE
Cheaper; world-class academic ecosystem; longer commute for London staff.
№ 03 / Licences & registrations

Get the paperwork done before you sign a lease.

UK figures for 2026. Lead times assume you submit complete applications — councils will pause the clock if you miss documents.

Requirement
Who issues
Cost
Lead time
ReqCompanies House Ltd + EMI + IP assignment + university spin-out terms
Companies House + solicitor + TTO
£3,400–£28,000
4–16 weeks
ReqHSE biosafety notification (CL2 / GMO work) + biosafety officer
HSE
£0 notification + £14k–£42k / yr BSO
4–12 weeks
OptHTA licence (human tissue) / HRA approval (clinical samples)
HTA / HRA
£2,400–£14,000 + £4,800 / yr
12–24 weeks
OptMHRA clinical-trial authorisation (CTIMP) / IND-equivalent
MHRA + ethics committee
£14,000–£82,000 + ongoing
16–36 weeks
OptISO 15189 (diagnostics) / ISO 13485 (medical device) / GxP (GLP / GMP / GCP)
UKAS / BSI / SGS
£24,000–£140,000 / yr
9–18 months
ReqICO + DPO + DPIA (clinical / genomic data)
ICO
£60 + £180–£600 / month
1–3 weeks
ReqPI + product-liability + employer's liability + cyber
Insurer
£3,400–£28,000 / yr
2–6 weeks
OptIP filings (priority + PCT) + freedom-to-operate
Patent attorney
£14,000–£82,000 / yr
Ongoing
№ 04 / Build-out timeline

From decision to open in 12 weeks.

01

Months 1–4 · Spin-out + wet-lab + biosafety

1–16
  • Topco + EMI + IP assignment + TTO spin-out terms (if applicable)
  • Co-lab bench booked (BioLabs / Stevenage / Babraham); biosafety officer engaged
  • HSE biosafety notification + first IP filings
  • ELN (Benchling) + LIMS + R&D-tax-credit accountant onboarded
02

Months 5–12 · Pre-seed milestones + grants

17–48
  • Innovate UK / ARIA / SBRI / Wellcome Leap grant submissions
  • First in vitro / in vivo proof-of-concept data
  • R&D tax credit yr-1 claim drafted
  • Pre-seed close (£600k–£1.4m blended grant + VC)
03

Months 13–24 · Seed + IND-enabling

49–96
  • ISO 15189 / ISO 13485 / GxP framework (if diagnostic / therapeutic)
  • IND-enabling / first-in-human prep (therapeutics) or 510k / UKCA-D (diagnostics)
  • KOL + pharma BD pipeline; 2–3 partnership conversations live
  • Seed close (£3m–£8m)
04

Months 25–36 · Series A or pharma BD

97–144
  • First clinical / pivotal data or BD term-sheet
  • Series A or pharma option-to-license deal
  • Scale-up wet-lab (own space or expanded co-lab)
  • Hire CMO / CSO / CBO as needed
№ 05 / Budget

Realistic startup and monthly cost ranges.

One-off · Startup

Setting up the shop

Legal + topco + EMI + IP + TTO spin-out
£14,000 → £82,000
Co-lab onboarding + biosafety setup
£14,000 → £60,000
Bench equipment (or co-lab inclusive)
£24,000 → £280,000
First 6 months ELN + LIMS + IP + compliance
£18,000 → £82,000
Pre-seed consumables + CRO + reagents
£40,000 → £200,000
Typical total
£110,000 – £704,000
Recurring · Monthly

Keeping the lights on

Co-lab benches (6–10 FTE)
£14,000 → £60,000
Consumables + reagents + CRO access
£8,000 → £42,000
Salaries (8 FTE blended £62k)
£36,000 → £54,000
Compliance + biosafety + IP + R&D-tax-credit
£3,400 → £18,000
Insurance + accounting + audit
£800 → £4,800
BD + travel + conferences
£1,400 → £14,000
Typical total
£63,600 – £192,800
№ 06 / Numbers that compound

How a biotech lab actually looks on a chart.

Interactive projections rebuilt from real UK operating data — toggle the views to see ramp, mix and weekly load.

12-month revenue ramp
Low vs high scenario (£ monthly)
High Low

Source · NAVIZIX 2026 London + Cambridge Pre-seed–Seed biotech cohort (n=11 labs, 4–14 FTE)

№ 07 / First 90 days

Dates that actually matter after opening.

01Day 0

Topco incorporated; TTO spin-out (if applicable) closed

02Day 60

Co-lab benches live; biosafety officer + HSE notification done

03Day 120

First IP filings; Innovate UK / ARIA grant submitted

04Day 240

First PoC data; R&D tax credit yr-1 claim drafted

05Day 420

Pre-seed closed (£600k–£1.4m blended)

06Day 720

Seed closed or pharma BD term-sheet; IND-enabling work begun

№ 08 / What's inside

DNA, route, automations, integrations, benchmarks, advisors — tuned for a biotech lab.

01Move
DNA dimensions

Programme stage (TRL / pre-IND / IND / Phase 1), data reproducibility, biosafety level (BSL-1/2/3), HTA / HRA / MHRA / HSE compliance, runway months, IP filings + freedom-to-operate, KOL + advisor density, BD / partnership pipeline.

02Move
Suggested route

Pick a modality (small-molecule / biologic / cell + gene / diagnostic / synbio / agri-bio), secure CL2 wet-lab space, embed GxP + ISO 15189 / ISO 13485 from day one (if diagnostic / therapeutic), and stage Innovate UK / ARIA / Wellcome Leap / SBRI grants before VC dilution.

03Move
Automations

Daily ELN + LIMS digest, weekly experimental-throughput + reproducibility report, monthly IP + freedom-to-operate update, biosafety + waste-disposal log, grant-milestone tracker, BD pipeline + KOL outreach automation.

04Move
Integrations

Benchling / LabArchives ELN, LabWare / STARLIMS, GraphPad + JMP + Spotfire, AWS / GCP for compute (cryo-EM / NGS), Labstep, HRA IRAS + MHRA portal, Salesforce + HubSpot (BD), Xero + R&D-tax-credit accountant.

05Move
Benchmarks

Experiments per FTE per week, reproducibility rate, grant-conversion rate, IP filings per £100k spend vs UK biotech cohort, refreshed quarterly.

06Move
Advisors

Encore advisors who founded / exited UK biotech + ran CL2 wet-labs + closed Innovate UK / ARIA / pharma BD deals, plus NAVIZIX AI for grant-eligibility + R&D-tax-credit modelling.

№ 09 / Stack

Modules used in this playbook.

01DNA Engine02Route Map03Launch Twin04Automation05Verified06Encore
Related playbooks

Owners of a biotech lab often run — or cross-sell with — these adjacent operations.

Playbook
SaaS startup
Open
Playbook
AI startup
Open
Playbook
Fintech startup
Open
Playbook
Healthtech startup
Open
Start with this playbook

14 days free. No credit card.

Full workspace, every module. The biotech lab playbook loads on day one. Cancel anytime.

Private preview · Waitlist

By requesting access you agree to our Terms and Privacy Policy.

3,751 operators in the queue
← All playbooksTalk to the founders →